Foy B D, Toner M, Tompkins R G, Yarmush M L
Surgical Services, Massachusetts General Hospital; Department of Surgery, Harvard Medical School; and the Shriners Burns Institute, Boston, Massachusetts 02114.
Biotechnol Bioeng. 1994 Mar 25;43(7):661-72. doi: 10.1002/bit.260430716.
The development and use of an extracorporeal liver support device depends upon the isolation of a large number of viable, functioning hepatocytes from whole or partial livers. Current practice, however, produces nonoptimal yields, given that a large percentage of hepatocytes initially present are not successfully isolated. The normal hepatocyte isolation protocol consists of sequential perfusion with calcium chelating and collagenase buffers, and then separation of viable hepatocytes from non-viable and nonparenchymal cells, usually on the basis of cell density. In order to improve understanding regarding the metabolic and perfusion state of the liver during this perfusion protocol, ATP, pH, and tissue perfusion were evaluated using nuclear magnetic resonance (NMR). Perfusion with calcium chelating buffer was found to have minimal effect on the metabolic and perfusion parameters, whereas subsequent perfusion with collagenase buffer produced large declines in ATP, pH, and homogeneity of perfusion within 3 min. Perfusion with calcium-chelating buffer alone, or perfusion with calcium chelating buffer followed by a short period of ischemia to mimic the perfusion disruption of collagenase, did not produce the same decline in metabolic parameters. This NMR data suggested that enhancing the early perfusion and penetration of collagenase or prolonging the nontoxic calcium-chelation step may improve the yield and/or functionality of isolated cells. Therefore, several altered perfusion protocols were evaluated in terms of yield of viable parenchymal hepatocytes and hepatocyte albumin production. Although increasing the perfusion flow rate and initial perfusion with inactive (cold) collagenase did not produce significant improvements when compared with the control protocol (control cell yield 226 +/- 42 x 10(6) viable hepatocytes for 10- to 14-week-old female Lewis rat), prolonging and enhancing the calcium-chelating perfusion step or increasing the collagenase concentration did yield a significantly great number of viable parenchymal hepatocytes (393 +/- 44 and 328 +/- 39 x 10(6) viable hepatocytes, respectively) with no change in albumin production per seeded viable cell. (c) 1994 John Wiley & Sons, Inc.
体外肝脏支持装置的研发与应用依赖于从全肝或部分肝脏中分离出大量有活力、能正常发挥功能的肝细胞。然而,鉴于最初存在的大部分肝细胞未能成功分离,目前的操作方法所获得的产量并不理想。正常的肝细胞分离方案包括依次用钙螯合缓冲液和胶原酶缓冲液进行灌注,然后通常根据细胞密度从无活力细胞和非实质细胞中分离出有活力的肝细胞。为了更好地了解在此灌注方案过程中肝脏的代谢和灌注状态,利用核磁共振(NMR)对三磷酸腺苷(ATP)、pH值和组织灌注进行了评估。结果发现,用钙螯合缓冲液灌注对代谢和灌注参数的影响极小,而随后用胶原酶缓冲液灌注在3分钟内导致ATP、pH值以及灌注均匀性大幅下降。单独用钙螯合缓冲液灌注,或先用钙螯合缓冲液灌注随后进行短时间缺血以模拟胶原酶灌注中断的情况,均未导致代谢参数出现同样程度的下降。这些核磁共振数据表明,增强胶原酶的早期灌注和渗透或延长无毒钙螯合步骤可能会提高分离细胞的产量和/或功能。因此,根据有活力的实质肝细胞产量和肝细胞白蛋白生成情况,对几种改变后的灌注方案进行了评估。尽管与对照方案相比,提高灌注流速以及先用无活性(冷)胶原酶进行初始灌注并未产生显著改善(对于10至14周龄雌性刘易斯大鼠,对照细胞产量为226±42×10⁶个有活力的肝细胞),但延长并增强钙螯合灌注步骤或提高胶原酶浓度确实产生了显著更多的有活力的实质肝细胞(分别为393±44和328±39×10⁶个有活力的肝细胞),且每个接种的有活力细胞的白蛋白生成量没有变化。(c)1994约翰·威利父子公司。